Romo-Nava F - Search Results

1

Clinical characterization of patients with bipolar disorder and a history of asthma: An exploratory study.

Romo-Nava F, Blom T, Cuellar-Barboza AB, Barrera FJ, Miola A, Mori NN, Prieto ML, Veldic M, Singh B, Gardea-Resendez M, Nunez NA, Ozerdem A, Biernacka JM, Frye MA, McElroy SL. Romo-Nava F, et al. J Psychiatr Res. 2023 Aug;164:8-14. doi: 10.1016/j.jpsychires.2023.05.061. Epub 2023 Jun 3. J Psychiatr Res. 2023. PMID: 37290273

2

Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

McElroy SL, Guerdjikova AI, Mori N, Romo-Nava F. McElroy SL, et al. CNS Drugs. 2019 Jan;33(1):31-46. doi: 10.1007/s40263-018-0594-5. CNS Drugs. 2019. PMID: 30523523 Review.

3

Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder.

Frye MA, Coombes BJ, McElroy SL, Jones-Brando L, Bond DJ, Veldic M, Romo-Nava F, Bobo WV, Singh B, Colby C, Skime MK, Biernacka JM, Yolken R. Frye MA, et al. JAMA Psychiatry. 2019 Dec 1;76(12):1285-1293. doi: 10.1001/jamapsychiatry.2019.2499. JAMA Psychiatry. 2019. PMID: 31532468 Free PMC article.

4

Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials.

Nunez NA, Singh B, Romo-Nava F, Joseph B, Veldic M, Cuellar-Barboza A, Cabello Arreola A, Vande Voort JL, Croarkin P, Moore KM, Biernacka J, McElroy SL, Frye MA. Nunez NA, et al. Bipolar Disord. 2020 Mar;22(2):109-120. doi: 10.1111/bdi.12859. Epub 2020 Jan 7. Bipolar Disord. 2020. PMID: 31643130

5

Evening chronotype as a discrete clinical subphenotype in bipolar disorder.

Romo-Nava F, Blom TJ, Cuellar-Barboza AB, Winham SJ, Colby CL, Nunez NA, Biernacka JM, Frye MA, McElroy SL. Romo-Nava F, et al. J Affect Disord. 2020 Apr 1;266:556-562. doi: 10.1016/j.jad.2020.01.151. Epub 2020 Jan 26. J Affect Disord. 2020. PMID: 32056926

6

Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorder.

Romo-Nava F, Blom TJ, Guerdjikova A, Winham SJ, Cuellar-Barboza AB, Nunez NA, Singh B, Biernacka JM, Frye MA, McElroy SL. Romo-Nava F, et al. Acta Psychiatr Scand. 2020 Jul;142(1):58-65. doi: 10.1111/acps.13179. Epub 2020 May 30. Acta Psychiatr Scand. 2020. PMID: 32335894

7

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection.

Cuéllar-Barboza AB, McElroy SL, Veldic M, Singh B, Kung S, Romo-Nava F, Nunez NA, Cabello-Arreola A, Coombes BJ, Prieto M, Betcher HK, Moore KM, Winham SJ, Biernacka JM, Frye MA. Cuéllar-Barboza AB, et al. Int J Bipolar Disord. 2020 Jul 4;8(1):23. doi: 10.1186/s40345-020-00184-3. Int J Bipolar Disord. 2020. PMID: 32632502 Free PMC article. Review.

8

Body mass index and blood pressure in bipolar patients: Target cardiometabolic markers for clinical practice.

Cuellar-Barboza AB, Cabello-Arreola A, Winham SJ, Colby C, Romo-Nava F, Nunez NA, Morgan RJ, Gupta R, Bublitz JT, Prieto ML, De Filippis EA, Lopez-Jimenez F, McElroy SL, Biernacka JM, Frye MA, Veldic M. Cuellar-Barboza AB, et al. J Affect Disord. 2021 Mar 1;282:637-643. doi: 10.1016/j.jad.2020.12.121. Epub 2020 Dec 29. J Affect Disord. 2021. PMID: 33445086

9

[No title available]

[No authors listed] [No authors listed] PMID: 33715657

10

The use of melatonin to mitigate the adverse metabolic side effects of antipsychotics.

Romo-Nava F, Buijs RM, McElroy SL. Romo-Nava F, et al. Handb Clin Neurol. 2021;179:371-382. doi: 10.1016/B978-0-12-819975-6.00024-8. Handb Clin Neurol. 2021. PMID: 34225976 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page